Integrative Gastroenterology - an Observational Trial

Universität Duisburg-Essen200 enrolled

Overview

This study aims to test, if a two-week integrative therapy in an internal medicine ward will improve symptoms, disability and quality of life in patients with inflammatory bowel disease or irritable bowel syndrome.a It shall further be tested, if those changes are associated with attitudes and experiences towards complementary and alternative medicine, anxiety, depression and stress perception as well as body awareness and responsiveness.

see above

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Crohns Disease Ulcerative Colitis Irritable Bowel Syndrome

Interventions

Integrative TherapyOTHER

This group receives an integrative therapy at the Department of Internal and Integrative Medicine, i.e. a combination of conventional diagnostic and therapeutic interventions with specific naturopathic, and complementary medicine approaches, and physical therapy.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years or older * diagnosed with Irritable Bowel Syndrome (IBS) or Inflammatory Bowel Disease (IBD) * written informed consent Exclusion Criteria: * participation in other clinical studies

Locations (1)

Department of Internal and Integrative Medicine, Kliniken Essen-Mitte

Essen, Germany

Outcomes

Primary Outcomes

Symptoms Severity IBS-SSS

Symptoms Severity assessed by Irritable Bowel Syndrome Symptom Severity Score (IBS-SSS) (Francis, 1997)

Time frame: 2 weeks

Symptoms Severity CAI

Symptoms Severity assessed by Clinical Activity Index (CAI) (Rachmilewitz 1989)

Time frame: 2 weeks

Symptoms Severity CDAI

Symptoms Severity assessed by Crohn Disease Activity Index (CDAI)

Time frame: 2 weeks

Secondary Outcomes

Symptoms Severity IBS-SSS

Symptoms Severity assessed by Irritable Bowel Syndrome Symptom Severity Score (IBS-SSS) (Francis, 1997)

Time frame: 24 weeks

Symptoms Severity CAI

Symptoms Severity assessed by Clinical Activity Index (CAI) (Rachmilewitz 1989)

Time frame: 24 weeks

Symptoms Severity CDAI

Symptoms Severity assessed by Crohn Disease Activity Index (CDAI)

Time frame: 24 weeks

Disability MYMOP

Disability assessed by Measure Yourself Medical Outcome Profile (MYMOP) (Paterson 1996)

Time frame: 2 weeks

Disability MYMOP

Disability assessed by Measure Yourself Medical Outcome Profile (MYMOP) (Paterson 1996)

Time frame: 24 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.